These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5150798)

  • 21. The requirement of capreomycin, ethambutol and rifampicin in chronic pulmonary tuberculosis in Helsinki on the basis of resistance indications.
    Tani P
    Scand J Respir Dis Suppl; 1969; 69():15-6. PubMed ID: 4313500
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1968; 65():195-206. PubMed ID: 4978461
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of isoniazid-resistant pulmonary tuberculosis with ethambutol, rifampicin and capreomycin: a co-operative study in England and Wales.
    Andrews RH; Jenkins PA; Marks J; Pines A; Selkon JB; Somner AR
    Tubercle; 1974 Jun; 55(2):105-13. PubMed ID: 4143450
    [No Abstract]   [Full Text] [Related]  

  • 24. A trial of intermittent rifampicin and ethambutol in retreatment regimens.
    Zierski M
    Scand J Respir Dis Suppl; 1973; 84():132-5. PubMed ID: 4522067
    [No Abstract]   [Full Text] [Related]  

  • 25. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
    Dubra F
    Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
    [No Abstract]   [Full Text] [Related]  

  • 26. The antituberculosis efficacy of rifampin in 136 patients.
    Davidson PT; Goble M; Lester W
    Chest; 1972 Jun; 61(6):574-8. PubMed ID: 4624279
    [No Abstract]   [Full Text] [Related]  

  • 27. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
    Semenova OV
    Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.
    Jeanes CW; Jessamine AG; Eidus L
    Can Med Assoc J; 1972 Apr; 106(8):884-8. PubMed ID: 4623743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary results with rifampicin in the treatment of drug-resistant tuberculosis.
    Pines A
    Tubercle; 1969 Mar; 50():Suppl:50-2. PubMed ID: 5402545
    [No Abstract]   [Full Text] [Related]  

  • 30. [Histobacteriology of pulmonary resection specimens in patients treated with rifampicin. Clinico-therapeutic conclusions].
    Palombini BC; Wallau CH; Tossin LN; Corrêa IF; Chaieb JA; Vieira VG; Ott WP; Nunes JD; Porto NS
    AMB Rev Assoc Med Bras; 1972 Sep; 18(9):349-54. PubMed ID: 4539257
    [No Abstract]   [Full Text] [Related]  

  • 31. Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis.
    Verbist L; Mbete S; Van Landuyt H; Darras T; Gyselen A
    Chest; 1972 Jun; 61(6):555-63. PubMed ID: 4624278
    [No Abstract]   [Full Text] [Related]  

  • 32. [ rpceedomgs" Intermittent 2-phase regimen in therapy of chronic pulmonary tuberculosis].
    Zierski M
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):116-23. PubMed ID: 4491708
    [No Abstract]   [Full Text] [Related]  

  • 33. Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis.
    Kohno S; Koga H; Kaku M; Maesaki S; Hara K
    Chest; 1992 Dec; 102(6):1815-8. PubMed ID: 1446494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 35. Rifampicin and ethambutol in retreatment of chronic pulmonary tuberculosis.
    Wiman LG; Johansson R; Tegner KB
    Scand J Respir Dis; 1973; 54(5):255-63. PubMed ID: 4777378
    [No Abstract]   [Full Text] [Related]  

  • 36. The Australian rifampicin trial.
    Proust A; Evans C
    Med J Aust; 1972 Oct; 2(16):861-7. PubMed ID: 4647286
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bacteriological analysis of patients treated with rifampicin and ethambutol under hospital and ambulatory conditions in Poznan in the years 1969-1972 with special reference to methods of patient surveillance].
    Krukowska-Grzezińska A; Chodera B; Klimczyk M; Kańczugowski W; Kubiaczyk T
    Gruzlica; 1974 May; 42(5):420-3. PubMed ID: 4464231
    [No Abstract]   [Full Text] [Related]  

  • 38. Pre- and postoperative treatment of chronic multiresistant cases of pulmonary tuberculosis with rifampicin.
    Rzepecki WM; Lodziak A
    Chemotherapy; 1974; 20(2):12-4. PubMed ID: 4367637
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
    Roslik SM; Iakovleva LM; Zhitnaia VI; Grushevskiĭ ES; Poluianova RP
    Probl Tuberk; 1980 Jun; (6):30-3. PubMed ID: 7393907
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative daily followed clinical study of treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin. Daily and intermittent method].
    Gruzlica; 1975 Dec; 43(12):1067-98. PubMed ID: 1193413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.